Lincoln International’s Global Healthcare Group Announces Strong Results in 2022
Lincoln International’s global Healthcare Group enjoyed another consecutive year of record-setting mergers and acquisitions (M&A) deal volume, average deal size and a record backlog heading in to 2023. Our performance is especially notable given global healthcare M&A volumes saw a modest pull back in 2022 brought on by instability in the labor market, higher inflation and interest rates, pressure on reimbursements and the waning influence of COVID-19-era government-funded supports.
Despite these macro influences, we expect 2023 to be another active year for healthcare dealmaking as industry players and private equity utilize M&A as a strategy to keep pace with the ever-increasing complexities across healthcare access, quality and cost; regulatory pressures; reimbursement rates; software and technology integration; payment reforms and advances in pharma and medical technology.
Our team has deep domain expertise and transaction experience across a number of high growth areas of the global healthcare economy including:
- Animal health
- Behavioral and mental health
- Fertility and women’s health
- Healthcare IT and tech-enabled services
- Home and community based care
- Labs and lab services
- Payor services and employer-funded insurance services
- Pharma and medtech outsourcing
- Physical / occupational / speech therapy and rehab
- Physician services and ambulatory care
- Value-based care enablement
- Revenue cycle management
Summary
-
Lincoln International's Global Healthcare Group announces strong results in 2022.
Select Notable 2022 Healthcare Transactions
Related Perspectives
Investors in Healthcare | Q&A with Lincoln Professionals
Originally posted by Investors in Healthcare on July 25, 2024. Lincoln International, the U.S.-headquartered global investment banking advisor, is a well-known name in the European healthcare markets, providing advice to… Read More
Outlook in the EU: PE has Ophthalmology Sector in its Sights
Across Europe, private clinics and specialist outpatient healthcare providers such as ophthalmology practices have seen a wave of consolidation, which has led to the emergence of several pan-European and more… Read More
Real Deals | Maintaining Momentum: The Outlook for M&A in the Healthcare Sector
Originally posted by Real Deals on May 31, 2024. RD: Which sub-sector of healthcare is currently attracting the most investment? Dirk-Oliver Löffler: Provider business is still one of the core… Read More
PETS International | Consolidation Meets Regulation in the Veterinary Clinics Market
Originally posted by PETS International on April 5, 2024. Animal health is becoming a big business in Europe and the U.S. Thus, regulators are turning a closer eye to mergers… Read More
Meet Our Senior Team in Healthcare
It’s extremely rewarding to work in one of the largest and most diverse global business sectors helping support clients to realize their goals.
Matthew Lee
Managing Director, Head of UK & European Co-head of Healthcare
London
I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Dirk-Oliver Löffler
Managing Director & Europe Co-head Healthcare
Frankfurt
My goal is to bring the best of Lincoln to each and every transaction, ensuring the topmost outcomes for our clients.
Roderick O’Neill
Managing Director & U.S. Co-head of Healthcare
New York
